Name: Pharma Tracker
Brand: Windmill Capital
SKU: AXTR_0002
Price: 41123 INR
Availability: OutOfStock

Nifty Largemidcap 250 Index

Depreciating rupee to boost profitability

Pharma Tracker

All publicly traded companies on the National Stock Exchange of India are sorted by marketcap. Only the top 750 companies on the basis of market cap are included in the universe

<ul><li>At Windmill Capital, our team crafts sector tracker portfolios to closely follow specific sectors and industries. The core thesis behind these portfolios is to achieve precise sector alignment by selecting stocks/ETFs that best represent the industry's growth and dynamics. Each selected stock or ETF undergoes a thorough evaluation process, which includes reviewing company’s investor presentations, conference calls, and sector reports to ensure a perfect theme alignment</li><li>Once potential stocks are shortlisted, they undergo rigorous evaluation based on fundamental factors, market share within the sector, and recent financial performance. This structured approach allows us to build high-conviction portfolios that effectively capture sector trends and opportunities</li><li>Pharma Tracker smallcase selects stocks/ETFs that are positioned to benefit from the growth of India’s pharmaceutical sector. It includes companies from pharmaceutical and life sciences industries</li></ul>

<ul><li>Stocks/ETFs qualifying the above mentioned research criteria are selected for further analysis</li><li>Proprietary liquidity filters are applied to remove ill-liquid stocks/ETFs from this list</li><li>A special check is further applied to remove stocks, where a significant part of the promoter holdings are pledged</li><li>Stocks/ETFs are further removed on the basis of red flags such as stock’s presence in ASM/GSM list of the exchanges, deep negative news or sentiment etc</li></ul>

The list of selected stocks is weighted such that the risk contribution of each stock in the smallcase is equal. By focusing on risk instead of marketcap or value, this weighting scheme provides better diversification and protection against market volatility

This smallcase has a quarterly rebalance schedule. Once every quarter, the research team reviews this smallcase and realign the weights with the selected asset allocation strategy for the next quarter

Compare with 101st-250th market cap stocks

Compare with 251st-350th market cap stocks

Compare with 101st-500th market cap stocks

Companies to efficiently track and invest in the pharma sector

Pharma Tracker

Overview

Stocks & Weights

smallcase is played out